Skip to main content

Advertisement

SpringerLink
Log in

Decreased olfactory bulb volumes in patients with fibromyalgia syndrome

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Among the other symptoms, impaired olfactory function such as odor identification, threshold, and discrimination have been reported in patients with fibromyalgia syndrome (FMS). To investigate olfactory bulb (OB) volumes in FMS, by using magnetic resonance imaging (MRI), and to make reasonable suggestions are the goals of the present study. The study included 62 individuals as the FMS group (n = 30) and the control group (n = 32). MRI examinations were performed by a 1.5-T scanner and a standard head coil was used for the images. The coronal T2-weighted images were used for to measure OB volumes. Right, left, and total OB volumes were calculated with the aid of these images. The mean age of the FMS group was 44.2 ± 8.3 years and the control group was 41.7 ± 3.53 years. The mean volume of the right OB was 74.9 ± 12.4 mm3 in the FMS group and was 92.6 ± 12.9 mm3 in the control group. The mean value of the left OB volume was 74.3 ± 10.8 mm3 in the FMS group and 92.8 ± 12.6 mm3 in the control group. The mean of the total OB volume was 146.6 ± 20.81 mm3 in the FMS group and 186.5 ± 23.5 mm3 in the control group. Left, right, and total OB volumes were significantly lower in the FMS group than in the control group (all p < 0.05). Female patients with FMS are under the risk of the decreased olfactory bulb volumes. This situation should be kept in mind for proper and reasonable management of this tough syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Williams DA, Clauw DJ (2009) Understanding fibromyalgia: lessons from the broader pain research community. J Pain 10:777–791

    Article  PubMed  PubMed Central  Google Scholar 

  2. Koklu K, Sarıgul M, Ozisler Z, Sirzai H, Ozel S (2016) Handgrip strength in fibromyalgia. Arch Rheumatol 31:158–161

    Article  Google Scholar 

  3. Branco JC et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448–453

    Article  PubMed  Google Scholar 

  4. Yazmalar L et al (2016) High frequency of fibromyalgia in patients with acne vulgaris. Arch Rheumatol 31:170–175

    Article  Google Scholar 

  5. Buschhüter D et al (2008) Correlation between olfactory bulb volume and olfactory function. NeuroImage 42:498–502

    Article  PubMed  Google Scholar 

  6. Doty RL (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol Dis 46:527–552

    Article  PubMed  Google Scholar 

  7. Moberg PJ et al (2013) Meta-analysis of olfactory function in schizophrenia, first degree family members, and youths at-risk for psychosis. Schizophr Bull 40:50–59

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ortega-Hernandez OD, Kivity S, Shoenfeld Y (2009) Olfaction, psychiatricdisorders and autoimmunity: is there a common geneticassociation. Autoimmunity 42:80–88

    Article  CAS  PubMed  Google Scholar 

  9. Demarquay G, Ryvlin P, Royet JP (2007) Olfaction and neurological diseases: a review of the literature. Rev Neurol (Paris) 163:155–167

    Article  CAS  Google Scholar 

  10. Strous RD, Shoenfeld Y (2006) To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 6:54–60

    Article  CAS  PubMed  Google Scholar 

  11. Leon-Sarmiento FE, Bayona EA, Bayona-Prieto J, Osman A, Doty RL (2012) Profound olfactory dysfunction in myasthenia gravis. PLoS One 7:e45544

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shoenfeld Y (2007) To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 28:165–169

    Article  CAS  PubMed  Google Scholar 

  13. Rombaux P, Duprez T, Hummel T (2009) Olfactory bulb volume in the clinical assessment of olfactory dysfunction. Rhinology 47:3–9

    CAS  PubMed  Google Scholar 

  14. Mueller A et al (2005) Olfactory bulb volumes in patients with idiopathic Parkinson’s disease a pilot study. J Neural Transm 112:1363–1370

    Article  CAS  PubMed  Google Scholar 

  15. Wilbarger JL, Cook DB (2011) Multisensory hypersensitivity in women with fibromyalgia: implications for well being and intervention. Arch Phys Med Rehabil 92:653–656

    Article  PubMed  PubMed Central  Google Scholar 

  16. Jörn L, Hans-Georg K, Jörg W, Thomas H (2012) Self-ratings of higher olfactory acuity contrast with reduced olfactory test results offibromyalgia patients. Int J Psychophysiol 86:182–186

    Article  Google Scholar 

  17. Howard A, Nancy AL (2014) Olfactory impairment in patients with thefibromyalgia syndrome and systemic sclerosis. Immunol Res 60:201–207

    Article  Google Scholar 

  18. Burgmer M et al (2012) Cerebral mechanisms of experimental hyperalgesia in fibromyalgia. Eur J Pain 16:636–647

    Article  CAS  PubMed  Google Scholar 

  19. Staud R (2011) Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol 29:109–117

    Google Scholar 

  20. Schweinhardt P, Sauro KM, Bushnell MC (2008) Fibromyalgia: a disorder of the brain. Neuroscientist 14:415–421

    Article  PubMed  Google Scholar 

  21. Lutz J et al (2008) White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 58:3960–3969

    Article  PubMed  Google Scholar 

  22. Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain. J Neurosci 27:4004–4007

    Article  CAS  PubMed  Google Scholar 

  23. Burgmer M et al (2009) Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 71(5):566–573

    Article  PubMed  Google Scholar 

  24. Martines-Marcos A (2009) On the organization of olfactory and vomeronasal cortices. Prog Neurobiol 87(1):21–30

    Article  Google Scholar 

  25. Arnold LM et al (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67(8):1219–1225

    Article  PubMed  Google Scholar 

  26. Sayılır S (2016) The relationship between symptom severity and cognitive functions of fibromyalgia syndrome with obesity. Turk J Osteoporos 22:129–131

    Google Scholar 

  27. Negoias S et al (2010) Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. Neuroscience 169(1):415–421

    Article  CAS  PubMed  Google Scholar 

  28. Drevets WC (1999) Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 877:614–637

    Article  CAS  PubMed  Google Scholar 

  29. Drevets WC, Bogers W, Raichle ME (2002) Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12:527–544

    Article  CAS  PubMed  Google Scholar 

  30. Wagner G, Koch K, Schachtzabel C, Reichenbach JR, Sauer H, Schlosser RG (2008) Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci 33:199–208

    PubMed  PubMed Central  Google Scholar 

  31. Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627–647

    Article  PubMed  Google Scholar 

  32. Taylor AG et al (2015) Stress, Inflammation and Pain: A Potential Role for Monocytes in Fibromyalgia-related Symptom Severity. Stress Health. doi:10.1002/smi.2648

  33. Bazzichi L et al (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25:225–230

    CAS  PubMed  Google Scholar 

  34. Selda B et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder. Rheumatol Int 25(3):188–190

    Article  Google Scholar 

  35. Jill MR, Sarantopoulos CD (2009) Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy. Med Hypotheses 73:177–183

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Muğla Sıtkı Koçman University, Muğla, Turkey

    Selçuk Sayılır

  2. Faculty of Medicine, Department of Radiology, Muğla Sıtkı Koçman University, Muğla, Turkey

    Neşat Çullu

Authors
  1. Selçuk Sayılır
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neşat Çullu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Selçuk Sayılır.

Ethics declarations

Disclosures

None.

Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sayılır, S., Çullu, N. Decreased olfactory bulb volumes in patients with fibromyalgia syndrome. Clin Rheumatol 36, 2821–2824 (2017). https://doi.org/10.1007/s10067-017-3772-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3772-9

Keywords

Search

Navigation